Quantifying Antimicrobial Exposure in Dogs From a Longitudinal Study

Bacterial resistance to antimicrobials (AMR) is a growing public health threat, and exposure to antimicrobials (AMs) is, on the whole, a major risk factor for the occurrence of AMR. During the past decade, a limited number of studies about AM exposure in dogs have been published, showing a noticeabl...

Full description

Bibliographic Details
Main Authors: María Méndez, Miguel A. Moreno
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2020.00545/full
_version_ 1818348025330794496
author María Méndez
Miguel A. Moreno
Miguel A. Moreno
author_facet María Méndez
Miguel A. Moreno
Miguel A. Moreno
author_sort María Méndez
collection DOAJ
description Bacterial resistance to antimicrobials (AMR) is a growing public health threat, and exposure to antimicrobials (AMs) is, on the whole, a major risk factor for the occurrence of AMR. During the past decade, a limited number of studies about AM exposure in dogs have been published, showing a noticeable diversity regarding numerators (AMU), denominators (population at risk), and indicators. The aim of this study is to show that metrics based on the most easily recorded data about treatments and a follow-up design are a promising method for a preliminary assessment of AM exposure in companion animals when more detailed data are not available. To quantify AM exposure, two simple indicators were used: the number of treatments (Ts) per 100 dogs and the number of treatments per 10 dog-years. Overall figures of AM exposure were 194 Ts/100_dogs (480 treatments and 248 dogs) and 18.4 Ts/10_dog-years (480 treatments and 95,171 dog-days), respectively. According to the administration route, AM exposure figures were 126 Ts/100 dogs (305 treatments and 242 dogs) and 12.1 Ts/10_dog-years (305 treatments and 92,059 dog-days) for systemic use and 66 Ts/100 dogs (160 treatments and 242 dogs) and 6.3 Ts/10_dog-years (160 treatments in 92,059 dog-days) for topical use. Since there is no current agreement regarding an indicator for quantifying AM exposure in dogs, in addition to other measures, the simplest indicators based on the most frequently available information should also be reported as a preliminary compromise for permitting a comparative analysis of the different scenarios.
first_indexed 2024-12-13T17:43:30Z
format Article
id doaj.art-057865334ee74a189bd02b99cba46d4e
institution Directory Open Access Journal
issn 2297-1769
language English
last_indexed 2024-12-13T17:43:30Z
publishDate 2020-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj.art-057865334ee74a189bd02b99cba46d4e2022-12-21T23:36:41ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692020-11-01710.3389/fvets.2020.00545548385Quantifying Antimicrobial Exposure in Dogs From a Longitudinal StudyMaría Méndez0Miguel A. Moreno1Miguel A. Moreno2Department of Animal Health, Veterinary Faculty, Complutense University, Madrid, SpainDepartment of Animal Health, Veterinary Faculty, Complutense University, Madrid, SpainVISAVET Center, Complutense University, Madrid, SpainBacterial resistance to antimicrobials (AMR) is a growing public health threat, and exposure to antimicrobials (AMs) is, on the whole, a major risk factor for the occurrence of AMR. During the past decade, a limited number of studies about AM exposure in dogs have been published, showing a noticeable diversity regarding numerators (AMU), denominators (population at risk), and indicators. The aim of this study is to show that metrics based on the most easily recorded data about treatments and a follow-up design are a promising method for a preliminary assessment of AM exposure in companion animals when more detailed data are not available. To quantify AM exposure, two simple indicators were used: the number of treatments (Ts) per 100 dogs and the number of treatments per 10 dog-years. Overall figures of AM exposure were 194 Ts/100_dogs (480 treatments and 248 dogs) and 18.4 Ts/10_dog-years (480 treatments and 95,171 dog-days), respectively. According to the administration route, AM exposure figures were 126 Ts/100 dogs (305 treatments and 242 dogs) and 12.1 Ts/10_dog-years (305 treatments and 92,059 dog-days) for systemic use and 66 Ts/100 dogs (160 treatments and 242 dogs) and 6.3 Ts/10_dog-years (160 treatments in 92,059 dog-days) for topical use. Since there is no current agreement regarding an indicator for quantifying AM exposure in dogs, in addition to other measures, the simplest indicators based on the most frequently available information should also be reported as a preliminary compromise for permitting a comparative analysis of the different scenarios.https://www.frontiersin.org/articles/10.3389/fvets.2020.00545/fullpetsantibioticsexposuremetricsfollow-upSpain
spellingShingle María Méndez
Miguel A. Moreno
Miguel A. Moreno
Quantifying Antimicrobial Exposure in Dogs From a Longitudinal Study
Frontiers in Veterinary Science
pets
antibiotics
exposure
metrics
follow-up
Spain
title Quantifying Antimicrobial Exposure in Dogs From a Longitudinal Study
title_full Quantifying Antimicrobial Exposure in Dogs From a Longitudinal Study
title_fullStr Quantifying Antimicrobial Exposure in Dogs From a Longitudinal Study
title_full_unstemmed Quantifying Antimicrobial Exposure in Dogs From a Longitudinal Study
title_short Quantifying Antimicrobial Exposure in Dogs From a Longitudinal Study
title_sort quantifying antimicrobial exposure in dogs from a longitudinal study
topic pets
antibiotics
exposure
metrics
follow-up
Spain
url https://www.frontiersin.org/articles/10.3389/fvets.2020.00545/full
work_keys_str_mv AT mariamendez quantifyingantimicrobialexposureindogsfromalongitudinalstudy
AT miguelamoreno quantifyingantimicrobialexposureindogsfromalongitudinalstudy
AT miguelamoreno quantifyingantimicrobialexposureindogsfromalongitudinalstudy